Translate
Neurosense Therapeutics Ltd
About
Neurosense Therapeutics Ltd (NASDAQ:NRSN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 6 2026
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
Apr 3 2026
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
Mar 31 2026
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
Mar 24 2026
NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout
Mar 18 2026
/C O R R E C T I O N -- NeuroSense/
Financials
Revenue
$0
Market Cap
$27.72 M
EPS
-0.44